Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Total 13F shares
-
232,062,084
-
Share change
-
-1,929,174
-
Total reported value
-
$46,728,254,072
-
Put/Call ratio
-
89%
-
Price per share
-
$201.63
-
Number of holders
-
961
-
Value change
-
-$411,655,570
-
Number of buys
-
490
-
Number of sells
-
453
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q2 2021
As of 30 Jun 2021,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
961 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
232,062,084 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, ALLIANCEBERNSTEIN L.P., FMR LLC, Clearbridge Investments, LLC, and Capital International Investors.
This page lists
962
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.